Antineoplastic Combined Chemotherapy Protocols Concept

subject area of

• 5-Fluorouracil with Folinic Acid is Not Effective Against Metastatic Adenocarcinoma of the Lung  Academic Article
• A Comparison of Elderly Patients with Aggressive Histology Lymphoma who Were Entered or Not Entered on to a Randomized Phase II Trial  Academic Article
• A National Cancer Institute of Canada Clinical Trials Group phase II study of eniluracil (776C85) and oral 5-fluorouracil in patients with advanced squamous cell head and neck cancer  Academic Article
• A Phase I Evaluation of Oral CI-1033 in Combination with Paclitaxel and Carboplatin as First-Line Chemotherapy in Patients with Advanced Non-small Cell Lung Cancer  Academic Article
• A Phase I Open-Label Dose-Escalation Study of Intravenous BI 2536 Together With Pemetrexed in Previously Treated Patients With Non–Small-Cell Lung Cancer  Academic Article
• A Phase I Study of OGX-011, a 2′-Methoxyethyl Phosphorothioate Antisense to Clusterin, in Combination with Docetaxel in Patients with Advanced Cancer  Academic Article
• A Phase I Study of Pegylated Liposomal Doxorubicin Hydrochloride (Caelyx™) in Combination with Cyclophosphamide and Vincristine as Second-Line Treatment of Patients with Small-Cell Lung Cancer  Academic Article
• A Phase I Study of Pomalidomide (CC-4047) in Combination with Cisplatin and Etoposide in Patients with Extensive-Stage Small-Cell Lung Cancer  Academic Article
• A Phase I Study of the combination of oxaliplatin/docetaxel and vandetanib for the treatment of advanced gastroesophageal cancer  Academic Article
• A Phase I Trial of Standard and Cyclophosphamide Dose-Escalated CHOP with Granulocyte Colony Stimulating Factor in Elderly Patients with Non-Hodgkin's Lymphoma  Academic Article
• A Phase I Trial of Tipifarnib With Radiation Therapy, With and Without Temozolomide, for Patients With Newly Diagnosed Glioblastoma  Academic Article
• A Phase I/II Study of GTI-2040 Plus Docetaxel as Second-Line Treatment in Advanced Non-small Cell Lung Cancer: A Study of the PMH Phase II Consortium  Academic Article
• A Phase II Study of PX-866 in Patients With Recurrent or Metastatic Castration-resistant Prostate Cancer: Canadian Cancer Trials Group Study IND205  Academic Article
• A Phase II study of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) and gemcitabine in advanced pancreatic carcinoma. A trial of the Princess Margaret Hospital Phase II consortium  Academic Article
• A Prospective Randomized Study of Alpha-2b Interferon plus Hydroxyurea or Cytarabine for Patients with Early Chronic Phase Chronic Myelogenous Leukemia: The International Oncology Study Group CML1 Study  Academic Article
• A Prospective, non-randomised phase 1–2 trial of VACOP-B with filgrastim support for HIV-related non-Hodgkin's lymphoma  Academic Article
• A Randomized Phase II Study of FOLFOX6/Bevacizumab With or Without Pelareorep in Patients With Metastatic Colorectal Cancer: IND.210, a Canadian Cancer Trials Group Trial  Academic Article
• A dose escalation trial of adjuvant cyclophosphamide and epirubicin in combination with 5-fluorouracil using G-CSF support for premenopausal women with breast cancer involving four or more positive nodes  Academic Article
• A fatal case ofPneumocystis jiroveciipneumonia in a breast cancer patient receiving weekly paclitaxel and trastuzumab  Academic Article
• A four gene signature of chromosome instability (CIN4) predicts for benefit from taxanes in the NCIC-CTG MA21 clinical trial  Academic Article
• A four gene signature predicts benefit from anthracyclines: evidence from the BR9601 and MA.5 clinical trials  Academic Article
• A meta-analysis of randomized controlled trials that compared neoadjuvant chemotherapy and surgery to surgery alone for resectable esophageal cancer  Academic Article
• A multicenter, randomized, open-label study to assess the steady-state pharmacokinetics of bevacizumab given with either XELOX or FOLFOX-4 in patients with metastatic colorectal cancer  Academic Article
• A multicentre, randomised trial comparing schedules of G-CSF (filgrastim) administration for primary prophylaxis of chemotherapy-induced febrile neutropenia in early stage breast cancer  Academic Article
• A pharmacogenetic analysis of the Canadian Cancer Trials Group MY.10 clinical trial of maintenance therapy for multiple myeloma  Academic Article
• A phase 1 trial evaluating thioridazine in combination with cytarabine in patients with acute myeloid leukemia  Academic Article
• A phase I study of OSI-211 and cisplatin as intravenous infusions given on days 1, 2 and 3 every 3 weeks in patients with solid cancers  Academic Article
• A phase I study of obatoclax mesylate, a Bcl-2 antagonist, plus topotecan in solid tumor malignancies  Academic Article
• A phase I study of the combination of ro4929097 and cediranib in patients with advanced solid tumours (PJC-004/NCI 8503)  Academic Article
• A phase I study of the oral gamma secretase inhibitor R04929097 in combination with gemcitabine in patients with advanced solid tumors (PHL-078/CTEP 8575)  Academic Article
• A phase I study of tipifarnib combined with conventional induction and consolidation therapy for previously untreated patients with acute myeloid leukemia aged 60 years and over  Academic Article
• A phase I trial of ANG1/2-Tie2 inhibitor trebaninib (AMG386) and temsirolimus in advanced solid tumors (PJC008/NCI♯9041)  Academic Article
• A phase I trial of high-dose paclitaxel, cyclophosphamide and mitoxantrone with autologous blood stem cell support for the treatment of metastatic breast cancer  Academic Article
• A phase I trial of two sequence-specific schedules of decitabine and vorinostat in patients with acute myeloid leukemia  Academic Article
• A phase I, dose-escalation trial of continuous- and pulsed-dose afatinib combined with pemetrexed in patients with advanced solid tumors  Academic Article
• A phase I/II study of sorafenib in combination with low dose cytarabine in elderly patients with acute myeloid leukemia or high-risk myelodysplastic syndrome from the National Cancer Institute of Canada Clinical Trials Group: trial IND.186  Academic Article
• A phase II study of doxorubicin/paclitaxel plus G-CSF for metastatic breast cancer.  Academic Article
• A phase II study of obatoclax mesylate, a Bcl-2 antagonist, plus topotecan in relapsed small cell lung cancer  Academic Article
• A phase II study of sorafenib in combination with bicalutamide in patients with chemotherapy-naive castration resistant prostate cancer  Academic Article
• A phase II study of the antisense oligonucleotide GTI-2040 plus docetaxel and prednisone as first-line treatment in castration-resistant prostate cancer  Academic Article
• A phase II trial of dovitinib in previously-treated advanced pleural mesothelioma: The Ontario Clinical Oncology Group  Academic Article
• A phase Ib combination study of RO4929097, a gamma-secretase inhibitor, and temsirolimus in patients with advanced solid tumors  Academic Article
• A phase I–II study of oblimersen sodium (G3139, Genasense) in combination with doxorubicin in advanced hepatocellular carcinoma (NCI # 5798)  Academic Article
• A pilot study of carboplatin augmentation therapy for patients with poor risk acute non-lymphocytic leukemia  Academic Article
• A pilot study of intensive cyclophosphamide, epirubicin and fluorouracil in patients with axillary node positive or locally advanced breast cancer  Academic Article
• A pilot study to investigate the feasibility and cardiac effects of pegylated liposomal doxorubicin (PL-DOX) as adjuvant therapy in medically fit elderly breast cancer patients  Academic Article
• A prognostic factor index for overall survival in patients receiving first-line chemotherapy for HER2-negative advanced breast cancer: An analysis of the ATHENA trial  Academic Article
• A randomised comparison of melphalan with prednisone or dexamethasone as induction therapy and dexamethasone or observation as maintenance therapy in multiple myeloma: NCIC CTG MY.7  Academic Article
• A randomized phase 3 trial of thalidomide and prednisone as maintenance therapy after ASCT in patients with MM with a quality-of-life assessment: the National Cancer Institute of Canada Clinicals Trials Group Myeloma 10 Trial  Academic Article
• A randomized phase II efficacy and safety study of vandetanib (ZD6474) in combination with bicalutamide versus bicalutamide alone in patients with chemotherapy naïve castration-resistant prostate cancer  Academic Article
• A randomized phase II study of cediranib alone versus cediranib in combination with dasatinib in docetaxel resistant, castration resistant prostate cancer patients  Academic Article
• A randomized trial comparing 12 weeks versus 36 weeks of adjuvant chemotherapy in stage II breast cancer.  Academic Article
• A randomized trial of maintenance versus no maintenance melphalan and prednisone in responding multiple myeloma patients  Academic Article
• A randomized, double-blind, window of opportunity trial evaluating the effects of chloroquine in breast cancer patients  Academic Article
• A randomized, open-label, multicentre, phase 2/3 study to evaluate the safety and efficacy of lumiliximab in combination with fludarabine, cyclophosphamide and rituximab versus fludarabine, cyclophosphamide and rituximab alone in subjects with relapsed ch  Academic Article
• A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma  Academic Article
• A systematic review of optimal treatment strategies for localized Ewing's sarcoma of bone after neo-adjuvant chemotherapy  Academic Article
• ABC 1 (1st International consensus guidelines for advanced breast cancer): A positive step  Academic Article
• ABVD Alone versus Radiation-Based Therapy in Limited-Stage Hodgkin's Lymphoma  Academic Article
• AML refractory to primary induction with Ida-FLAG has a poor clinical outcome  Academic Article
• Abdominopelvic cytoreduction rates and recurrence sites in stage IV ovarian cancer: Is there a case for thoracic cytoreduction?  Academic Article
• Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy  Academic Article
• Absence of Secondary Malignant Neoplasms in Children With High-Risk Acute Lymphoblastic Leukemia Treated With Dexrazoxane  Academic Article
• Activity of cabozantinib after immune checkpoint blockade in metastatic clear-cell renal cell carcinoma  Academic Article
• Activity of fulvestrant in HER2-overexpressing advanced breast cancer  Academic Article
• Acute Perforative Appendicitis During Preoperative Chemotherapy for Wilms Tumor  Academic Article
• Acute lymphoid leukemia. No evidence of consistent chemotherapy-induced intestinal malabsorption.  Academic Article
• Acute myelogenous leukemia in adolescents and young adults  Academic Article
• Addition of verapamil and tamoxifen to the initial chemotherapy of small cell lung cancer a phase I/II study  Academic Article
• Addressing taxane resistance in metastatic castration-resistant prostate cancer: a focus on chaperone proteins  Academic Article
• Adjuvant Anti-HER2 Therapy, Treatment-Related Amenorrhea, and Survival in Premenopausal HER2-Positive Early Breast Cancer Patients  Academic Article
• Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer  Academic Article
• Adjuvant Chemotherapy Is Associated With Improved Overall Survival in Locally Advanced Rectal Cancer After Achievement of a Pathologic Complete Response to Chemoradiation  Academic Article
• Adjuvant Chemotherapy With or Without Biologics Including Antiangiogenics and Monoclonal Antibodies Targeting EGFR and EpCAM in Colorectal Cancer: A Systematic Review and Meta-analysis  Academic Article
• Adjuvant Chemotherapy for Breast Cancer — 30 Years Later  Academic Article
• Adjuvant Chemotherapy for Stage II and III Colon Cancer Following Complete Resection: A Cancer Care Ontario Systematic Review  Academic Article
• Adjuvant Lapatinib and Trastuzumab for Early Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Results From the Randomized Phase III Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization Trial  Academic Article
• Adjuvant Systemic Therapy and Adjuvant Radiation Therapy for Stage I to IIIA Completely Resected Non–Small-Cell Lung Cancers: American Society of Clinical Oncology/Cancer Care Ontario Clinical Practice Guideline Update  Academic Article
• Adjuvant Therapy for Breast Cancer: We Are Solving the Puzzle, But Pieces Are Still Missing  Academic Article
• Adjuvant Therapy for Premenopausal Women With Breast Cancer: Is It Time for Another Paradigm Shift?  Academic Article
• Adjuvant Therapy for Stage II Colon Cancer: A Systematic Review From the Cancer Care Ontario Program in Evidence-Based Care’s Gastrointestinal Cancer Disease Site Group  Academic Article
• Adjuvant Therapy for completely resected Stage II Colon Cancer  Academic Article
• Adjuvant Treatment in Non-Small Cell Lung Cancer: Where Are We Now?  Academic Article
• Adjuvant chemotherapy and timing of tamoxifen in postmenopausal patients with endocrine-responsive, node-positive breast cancer: a phase 3, open-label, randomised controlled trial  Academic Article
• Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data  Academic Article
• Adjuvant chemotherapy in oestrogen-receptor-poor breast cancer: patient-level meta-analysis of randomised trials  Academic Article
• Adjuvant endocrine therapy of breast cancer  Academic Article
• Adjuvant sunitinib following chemoradiotherapy and surgery for locally advanced esophageal cancer: a phase II trial  Academic Article
• Adjuvant therapy for resected non-small-cell lung cancer: Past, present, and future  Academic Article
• Adriamycin and cisplatin in the treatment of stage III and IV epithelial ovarian carcinoma  Academic Article
• Advanced Ovarian Cancer: Phase III Randomized Study of Sequential Cisplatin–Topotecan and Carboplatin–Paclitaxel vs Carboplatin–Paclitaxel  Academic Article
• Alemtuzumab and CHOP Chemotherapy for the Treatment of Aggressive Histology Peripheral T Cell Lymphomas: A Multi-Center Phase I Study  Academic Article
• Altered mineral metabolism and bone mass in children during treatment for acute lymphoblastic leukemia  Academic Article
• An atypical case of bilateral posterior scleritis in a patient with chronic lymphocytic leukemia  Academic Article
• An individual patient-data comparison of combined modality therapy and ABVD alone for patients with limited-stage Hodgkin lymphoma  Academic Article
• An investigation of toxicities and survival in Hispanic children and adolescents with ALL: Results from the Dana-Farber Cancer Institute ALL Consortium protocol 05-001  Academic Article
• Analysis of Regional Timelines To Set Up a Global Phase III Clinical Trial in Breast Cancer: The Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization Experience  Academic Article
• Analysis of dose intensity for adjuvant chemotherapy trials in stage II breast cancer.  Academic Article
• Analysis of dose intensity for chemotherapy in early (stage II) and advanced breast cancer.  Academic Article
• Anastrozole as an Adjuvant Endocrine Treatment for Postmenopausal Patients with Breast Cancer: Emerging Data  Conference Paper
• Antiangiogenic therapies in non-small-cell lung cancer  Academic Article
• Anticoagulation and Bleeding: A Pooled Analysis of Lung Cancer Trials of the NCIC Clinical Trials Group  Academic Article
• Apatorsen plus docetaxel versus docetaxel alone in platinum-resistant metastatic urothelial carcinoma (Borealis-2)  Academic Article
• Assessing brain volume changes in older women with breast cancer receiving adjuvant chemotherapy: a brain magnetic resonance imaging pilot study  Academic Article
• Assessment of Referral and Chemotherapy Treatment Patterns for Elderly Patients With Non–small-Cell Lung Cancer  Academic Article
• Association of low tumor RNA integrity with response to chemotherapy in breast cancer patients  Academic Article
• Autologous Stem Cell Transplantation in Follicular Lymphoma: a Systematic Review and Meta-analysis  Academic Article
• Autologous Transplantation as Consolidation for Aggressive Non-Hodgkin's Lymphoma  Academic Article
• Autologous hematopoietic stem cell transplantation following high dose chemotherapy for non-rhabdomyosarcoma soft tissue sarcomas  Academic Article
• Autologous transplantation as consolidation for high risk aggressive T-cell non-Hodgkin lymphoma: a SWOG 9704 intergroup trial subgroup analysis  Conference Paper
• Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia  Academic Article
• Balancing Risks and Benefits of Therapy for Patients with Favorable-Risk Limited-Stage Hodgkin Lymphoma  Academic Article
• Better Treatments That Cost More: The Dilemma  Academic Article
• Biliary Rhabdomyosarcoma in an Infant Male With Neurofibromatosis Type 1  Academic Article
• Bleomycin-Induced Lung Toxicity and Pentoxifylline  Academic Article
• Bortezomib Added to R-CVP Is Safe and Effective for Previously Untreated Advanced-Stage Follicular Lymphoma: A Phase II Study by the National Cancer Institute of Canada Clinical Trials Group  Academic Article
• Canadian Cancer Trials Group (CCTG) IND211: A randomized trial of pelareorep (Reolysin) in patients with previously treated advanced or metastatic non-small cell lung cancer receiving standard salvage therapy  Academic Article
• Canadian Cancer Trials Group (CCTG) IND215: A phase Ib study of Selumetinib in patients with untreated advanced or metastatic NSCLC who are receiving standard chemotherapy regimens  Academic Article
• Cancer Care Ontario and American Society of Clinical Oncology Adjuvant Chemotherapy and Adjuvant Radiation Therapy for Stages I-IIIA Resectable Non–Small-Cell Lung Cancer Guideline  Academic Article
• Candidemia in women with breast carcinoma treated with high-dose chemotherapy and autologous bone marrow transplantation  Academic Article
• Carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in partially platinum-sensitive ovarian cancer patients: results from a subset analysis of the CALYPSO phase III trial  Academic Article
• Carboplatin hypersensitivity presenting as coronary vasospasm - a case report  Academic Article
• Cardiac safety of adjuvant pegylated liposomal doxorubicin with concurrent trastuzumab: a randomized phase II trial  Academic Article
• Cervical Cancer During Pregnancy  Academic Article
• Checkpoint inhibitors in patients with metastatic renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium  Academic Article
• Chemoradiotherapy with or without panitumumab in patients with unresected, locally advanced squamous-cell carcinoma of the head and neck (CONCERT-1): a randomised, controlled, open-label phase 2 trial  Academic Article
• Chemosensitization of gemcitabine-resistant human bladder cancer cell line bothin vitroandin vivousing antisense oligonucleotide targeting the anti-apoptotic gene, clusterin  Academic Article
• Chemotherapy Toxicity in BRCA Mutation Carriers Undergoing First‐Line Platinum‐Based Chemotherapy  Academic Article
• Chemotherapy and endocrine therapy in metastatic disease.  Academic Article
• Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial.  Academic Article
• Chemotherapy for Older Patients with Newly Diagnosed, Advanced-Stage, Aggressive-Histology Non-Hodgkin Lymphoma  Academic Article
• Chemotherapy for advanced non-small-cell lung cancer: how much benefit is enough?  Academic Article
• Chemotherapy for colorectal cancer  Academic Article
• Chemotherapy induced amenorrhoea in a randomised trial of adjuvant chemotherapy duration in breast cancer  Academic Article
• Chemotherapy with gemcitabine-containing regimens for locally recurrent or metastatic nasopharyngeal carcinoma  Academic Article
• Chemotherapy-induced infiltrative pneumonitis cases in breast cancer patients  Academic Article
• Childhood Atypical Teratoid Rhabdoid Tumor of the Central Nervous System  Academic Article
• Clinical application of the concept of methotrexate plus 5-FU sequence-dependent "synergy": how good is the evidence?  Academic Article
• Clinical cooperative trials of the National Cancer Institute of Canada Clinical Trials Group Breast Cancer Site Group.  Academic Article
• Clinical evidence of a cumulative effect of high-dose cytarabine on the cerebellum in patients with acute leukemia: a leukemia intergroup report.  Academic Article
• Clinical outcomes of ethnic minority women in MA.17: a trial of letrozole after 5 years of tamoxifen in postmenopausal women with early stage breast cancer  Academic Article
• Clinical practice guidelines for the care and treatment of breast cancer: 15. Treatment for women with stage III or locally advanced breast cancer  Academic Article
• Clinical trial update: National Cancer Institute of Canada  Academic Article
• Cognitive Function in Patients With Colorectal Cancer Who Do and Do Not Receive Chemotherapy: A Prospective, Longitudinal, Controlled Study  Academic Article
• Cohort Study of Somatostatin-Based Radiopeptide Therapy With [90Y-DOTA]-TOC Versus [90Y-DOTA]-TOC Plus [177Lu-DOTA]-TOC in Neuroendocrine Cancers  Academic Article
• Colorectal Cancer in Young Adults  Academic Article
• Colorectal cancer in adolescents and young adults: Defining a growing threat  Academic Article
• Combination 13-cis-retinoic acid and interferon alpha-2a in the therapy of solid tumors.  Academic Article
• Combination Epigenetic Therapy Has Efficacy in Patients with Refractory Advanced Non–Small Cell Lung Cancer  Academic Article
• Combination chemotherapy with bleomycin, etoposide, and cisplatin in metastatic non-small-cell lung cancer.  Academic Article
• Combined Modality Therapy of Esophageal Cancer  Academic Article
• Combined Stimulation with Interleukin-18 and Interleukin-12 Potently Induces Interleukin-8 Production by Natural Killer Cells  Academic Article
• Combined Treatment of a Murine Breast Cancer Model with Type 5 Adenovirus Vectors Expressing Murine Angiostatin and IL-12: A Role for Combined Anti-Angiogenesis and Immunotherapy  Academic Article
• Combined chemotherapy and radiation therapy for non-small-cell lung cancer.  Academic Article
• Combined methotrexate–dactinomycin: An effective therapy for low-risk gestational trophoblastic neoplasia  Academic Article
• Combined modality induction therapy without maintenance chemotherapy for small cell carcinoma of the lung.  Academic Article
• Combined modality radiotherapy and chemotherapy in nonsurgical management of localized carcinoma of the esophagus  Academic Article
• Combined modality therapy of Hodgkin's disease: 10-year results of National Cancer Institute of Canada Clinical Trials Group multicenter clinical trial.  Academic Article
• Combining Gemcitabine and Capecitabine in Patients With Advanced Biliary Cancer: A Phase II Trial  Conference Paper
• Commentary: Anthracyclines in Early‐Stage Breast Cancer: Is It the End of an Era?  Academic Article
• Comparison of Outcomes of Phase II Studies and Subsequent Randomized Control Studies Using Identical Chemotherapeutic Regimens  Conference Paper
• Comparison of infectious complications during induction/consolidation chemotherapy versus allogeneic hematopoietic stem cell transplantation  Academic Article
• Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials  Academic Article
• Complementary and Alternative Medicine Use Among Women Receiving Chemotherapy for Ovarian Cancer in 2 Patient Populations  Academic Article
• Concurrent Cisplatin-based Chemotherapy plus Radiotherapy for Cervical Cancer:  Academic Article
• Concurrent Cisplatin-based Chemotherapy plus Radiotherapy for Cervical Cancer–a Meta-analysis  Academic Article
• Consolidation Therapy With Autologous Bone Marrow Transplantation in Adults With Acute Myeloid Leukemia: A Meta-analysis  Academic Article
• Controlling angiogenesis in breast cancer: A systematic review of anti-angiogenic trials  Academic Article
• Conventional and Complementary Therapies: A Tale of Two Research Standards?  Academic Article
• Cost-effectiveness of a Transplantation Strategy Compared to Melphalan and Prednisone in Younger Patients with Multiple Myeloma  Academic Article
• Current Delivery of Hyperthermic Intraperitoneal Chemotherapy with Cytoreductive Surgery (CS/HIPEC) and Perioperative Practices: An International Survey of High-Volume Surgeons  Academic Article
• Current approaches to the treatment of advanced-stage Hodgkin's disease.  Academic Article
• Current approaches to the treatment of advanced-stage non-Hodgkin's lymphoma.  Academic Article
• Current status and future innovations of hormonal agents, chemotherapy and investigational agents in endometrial cancer  Academic Article
• Current status of adjuvant endocrine therapy for resectable breast cancer.  Academic Article
• Custirsen (OGX-011) combined with cabazitaxel and prednisone versus cabazitaxel and prednisone alone in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel (AFFINITY): a randomised, open-label, international, phase 3 trial  Academic Article
• Custirsen in combination with docetaxel and prednisone for patients with metastatic castration-resistant prostate cancer (SYNERGY trial): a phase 3, multicentre, open-label, randomised trial  Academic Article
• Cyclophosphamide and fluorouracil combined with mitoxantrone versus doxorubicin for breast cancer: superiority of doxorubicin.  Academic Article
• Cyclophosphamide, Epirubicin, and Fluorouracil Versus Dose-Dense Epirubicin and Cyclophosphamide Followed by Paclitaxel Versus Doxorubicin and Cyclophosphamide Followed by Paclitaxel in Node-Positive or High-Risk Node-Negative Breast Cancer  Academic Article
• Cytoreduction and hyperthermic intraperitoneal chemotherapy (CS/HIPEC) in colorectal cancer: Evidence-based review of patient selection and treatment algorithms  Academic Article
• Dalteparin Low Molecular Weight Heparin (LMWH) in ovarian cancer: A phase II randomized study  Academic Article
• Decision Framework for Chemotherapeutic Interventions for Metastatic Non-Small-Cell Lung Cancer  Academic Article
• Desmoplastic small round cell tumor presenting in the ovaries: Report of a case and review of the literature  Academic Article
• Detection of a clone-specific GATA1 mutation to monitor treatment response and involvement of a monozygotic twin in myeloid leukemia of Down syndrome  Academic Article
• Disabling Encephalopathy During 5-Fluorouracil and Levamisole Adjuvant Therapy for Resected Colorectal Cancer: A Report of Two Cases  Academic Article
• Docetaxel Plus Prednisone or Mitoxantrone Plus Prednisone for Advanced Prostate Cancer: Updated Survival in the TAX 327 Study  Academic Article
• Does the Addition of Biologic Agents to Chemotherapy in Patients with Unresectable Colorectal Cancer Metastases Result in a Higher Proportion of Patients Undergoing Resection? A Systematic Review and Meta-analysis  Academic Article
• Donor leukocyte infusions for multiple myeloma  Academic Article
• Dose intensity and lymphoma.  Academic Article
• Double heterozygosity for germline mutations in BRCA1 and p53 in a woman with early onset breast cancer  Academic Article
• Drug-Induced Stomatocytosis and Anemia During Consolidation Chemotherapy of Childhood Acute Leukemia  Academic Article
• Dual-Agent Molecular Targeting of the ErbB2 Receptor: Killing One Bird With Two Stones  Academic Article
• Durable Clinical Benefit in Metastatic Renal Cell Carcinoma Patients Who Discontinue PD-1/PD-L1 Therapy for Immune-Related Adverse Events  Academic Article
• Duration of Androgen Suppression Before Radiotherapy for Localized Prostate Cancer: Radiation Therapy Oncology Group Randomized Clinical Trial 9910  Academic Article
• Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial  Academic Article
• Dynamic Angiogenic Switch as Predictor of Response to Chemotherapy-Bevacizumab in Patients With Metastatic Colorectal Cancer  Academic Article
• Dyspermia in men with localized Hodgkin's disease. A potentially reversible, immune-mediated disorder  Academic Article
• EBV DNA: a Hodgkin lymphoma biomarker?  Academic Article
• Early Occurrence of Angiosarcoma in a Woman With a BRCA2 Gene Variation of Unknown Significance Treated With Breast-Conserving Therapy for Bilateral Ductal Carcinoma: A Case Report  Academic Article
• Early and late changes in markers of aortic stiffness with breast cancer therapy  Academic Article
• Early prediction of therapy responses and outcomes in breast cancer patients using quantitative ultrasound spectral texture  Academic Article
• Early-stage Hodgkin's disease: current approaches to treatment.  Academic Article
• Economic Evaluation of Bevacizumab for the First-Line Treatment of Newly Diagnosed Glioblastoma Multiforme  Academic Article
• Effect of Combined Immune Checkpoint Inhibition vs Best Supportive Care Alone in Patients With Advanced Colorectal Cancer  Academic Article
• Effect of disease and chemotherapy on hemostasis in children with acute lymphoid leukemia.  Academic Article
• Effect of the addition of rituximab to salvage chemotherapy prior to autologous stem cell transplant in aggressive CD20+ lymphoma: a cohort comparison from the NCIC Clinical Trials Group Study LY.12*  Academic Article
• Effect of visceral metastases on the efficacy and safety of everolimus in postmenopausal women with advanced breast cancer: Subgroup analysis from the BOLERO-2 study  Academic Article
• Effect of zoledronic acid on the doxycycline-induced decrease in tumour burden in a bone metastasis model of human breast cancer  Academic Article
• Effectiveness of antibacterial prophylaxis during induction chemotherapy in children with acute lymphoblastic leukemia  Academic Article
• Effects of a treatment gap during adjuvant chemotherapy in node-positive breast cancer: results of International Breast Cancer Study Group (IBCSG) Trials 13-93 and 14-93  Academic Article
• Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials  Academic Article
• Efficacy and safety of rolapitant for prevention of chemotherapy-induced nausea and vomiting over multiple cycles of moderately or highly emetogenic chemotherapy  Academic Article
• Efficacy of Letrozole Extended Adjuvant Therapy According to Estrogen Receptor and Progesterone Receptor Status of the Primary Tumor: National Cancer Institute of Canada Clinical Trials Group MA.17  Conference Paper
• Efficacy of docetaxel-based chemotherapy following ketoconazole in metastatic castration-resistant prostate cancer: Implications for prior therapy in clinical trials  Academic Article
• Eight Cycles of ABVD Versus Four Cycles of BEACOPPescalated Plus Four Cycles of BEACOPPbaseline in Stage III to IV, International Prognostic Score ≥ 3, High-Risk Hodgkin Lymphoma: First Results of the Phase III EORTC 20012 Intergroup Trial  Academic Article
• Endocrine and targeted manipulation of breast cancer: Summary statement for the Sixth Cambridge Conference  Academic Article
• Endocrine disorders following treatment of childhood brain tumours  Academic Article
• Endodermal Sinus Tumor in Pregnancy  Academic Article
• Enhanced eryptosis contributes to anemia in lung cancer patients  Academic Article
• Enhancing Endocrine Therapy Combination Strategies for the Treatment of Postmenopausal HR+/HER2– Advanced Breast Cancer  Academic Article
• Epidermal Growth Factor Receptor: Pathway, Therapies, and Pipeline  Academic Article
• Epirubicin, alone or in combination chemotherapy, for metastatic breast cancer. Provincial Breast Cancer Disease Site Group and the Provincial Systemic Treatment Disease Site Group.  Academic Article
• Escalated as Compared with Standard Doses of Doxorubicin in BACOP Therapy for Patients with Non-Hodgkin's Lymphoma  Academic Article
• Evaluating the Value of Number of Cycles of Docetaxel and Prednisone in Men With Metastatic Castration-Resistant Prostate Cancer  Academic Article
• Evaluation of Adverse Events Experienced by Older Patients Participating in Studies of Molecularly Targeted Agents Alone or in Combination  Academic Article
• Everolimus Plus Exemestane in Postmenopausal Patients with HR+ Breast Cancer: BOLERO-2 Final Progression-Free Survival Analysis  Academic Article
• Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast Cancer  Academic Article
• Evidence for a dose-response effect between p53 (but not p21WAF1/Cip1) protein concentrations, survival, and responsiveness in patients with epithelial ovarian cancer treated with platinum-based chemotherapy.  Conference Paper
• Evidence-based focused review of the role of radiation therapy in the treatment of early-stage Hodgkin lymphoma  Academic Article
• Evidence-based guideline recommendations on treatment strategies for localized Ewing's sarcoma of bone following neo-adjuvant chemotherapy  Academic Article
• Examining the safety and efficacy of a chemotherapy dosing method in Allogeneic Stem Cell Transplant patients of extreme body size  Academic Article
• Exogenous estrogen therapy, testicular cancer, and the male to female transgender population: a case report  Academic Article
• Expanded phase II trial of gemcitabine and capecitabine for advanced biliary cancer  Academic Article
• Expression of p27 in Residual Rectal Cancer after Preoperative Chemoradiation Predicts Long-term Outcome  Academic Article
• Fatigue in people with localized colorectal cancer who do and do not receive chemotherapy: a longitudinal prospective study  Academic Article
• Favorable Outcomes from Allogeneic and Autologous Stem Cell Transplantation for Patients with Transformed Nonfollicular Indolent Lymphoma  Academic Article
• Feasibility and efficacy of repeated chemotherapy for progressive pediatric low-grade gliomas  Academic Article
• Final Results of a Randomized Phase III Trial Comparing Cyclophosphamide, Epirubicin, and Fluorouracil With a Dose-Intensified Epirubicin and Cyclophosphamide + Filgrastim as Neoadjuvant Treatment in Locally Advanced Breast Cancer: An EORTC-NCIC-SAKK Multicenter Study  Academic Article
• Final overall survival results and effect of prolonged (≥1 year) first-line bevacizumab-containing therapy for metastatic breast cancer in the ATHENA trial  Academic Article
• First line therapy with paclitaxel (Taxol®) and pegylated liposomal doxorubicin (Caelyx®) in patients with metastatic breast cancer: a multicentre phase II study  Academic Article
• First-Line Systemic Chemotherapy in the Treatment of Advanced Non-small Cell Lung Cancer: A Systematic Review  Academic Article
• First-line bevacizumab plus taxane-based chemotherapy for locally recurrent or metastatic breast cancer: safety and efficacy in an open-label study in 2251 patients  Academic Article
• Five-Factor Prognostic Model for Survival of Post-Platinum Patients with Metastatic Urothelial Carcinoma Receiving PD-L1 Inhibitors  Academic Article
• Forearm pyomyositis in a breast cancer patient on chemotherapy  Academic Article
• Foreign Body Reaction Mimicking Breast Carcinoma in Patient with Stage IV Ovarian Cancer  Academic Article
• Future Directions for Research onSilybum marianumfor Cancer Patients  Academic Article
• Gemcitabine and paclitaxel associated pneumonitis in non-small cell lung cancer  Academic Article
• Gemcitabine and vinorelbine in recurrent advanced non-small cell lung cancer: sequence does matter  Academic Article
• Gemcitabine concurrent with continuous infusional 5-fluorouracil in advanced biliary cancers: a review of the Princess Margaret Hospital experience  Academic Article
• Gemcitabine, dexamethasone and cisplatin is an active andnon-toxic chemotherapy regimen in relapsed or refractory Hodgkin’s disease: a phase II study by the National Cancer Institute of Canada Clinical Trials Group  Academic Article
• Gemcitabine, dexamethasone, and cisplatin in patients with recurrent or refractory aggressive histology B-cell non-Hodgkin lymphoma  Academic Article
• Gemcitabine/Dexamethasone/Cisplatin vs Cytarabine/Dexamethasone/Cisplatin for Relapsed or Refractory Aggressive-Histology Lymphoma: Cost-Utility Analysis of NCIC CTG LY.12  Academic Article
• Global, multicenter, randomized, phase II trial of gemcitabine and gemcitabine plus AGS-1C4D4 in patients with previously untreated, metastatic pancreatic cancer  Academic Article
• Guideline for the Initial Management of Small Cell Lung Cancer (Limited and Extensive Stage) and the Role of Thoracic Radiotherapy and First-line Chemotherapy  Academic Article
• Guideline for the classification of the acute emetogenic potential of antineoplastic medication in pediatric cancer patients  Academic Article
• HER2 and TOP2A as predictive markers for anthracycline-containing chemotherapy regimens as adjuvant treatment of breast cancer: a meta-analysis of individual patient data  Academic Article
• HER2and Responsiveness of Breast Cancer to Adjuvant Chemotherapy  Academic Article
• HSP90 inhibition alters the chemotherapy-driven rearrangement of the oncogenic secretome  Academic Article
• Health Status and Health-related Quality of Life Measurement in Pediatric Cancer Clinical Trials  Academic Article
• Health-related quality of life and disease symptoms in postmenopausal women with HR+, HER2−advanced breast cancer treated with everolimus plus exemestane versus exemestane monotherapy  Academic Article
• Health-related quality of life of patients with advanced breast cancer treated with everolimus plus exemestane versus placebo plus exemestane in the phase 3, randomized, controlled, BOLERO-2 trial  Academic Article
• Hematopoietic colony-stimulating factor priming does not influence survival in acute myeloid leukemia: a meta-analysis of randomized trials  Academic Article
• Hemophagocytic Lymphohistiocytosis Onset During Induction Therapy for Precursor B-cell Acute Lymphoblastic Leukemia  Academic Article
• Hepatitis B, Rituximab, Screening, and Prophylaxis: Effectiveness and Cost Effectiveness  Academic Article
• High Dose Therapy with Stem Cell Support for Breast Cancer: The Jury Is Still Out  Academic Article
• High-dose Chemotherapy with Stem Cell Rescue as Initial Therapy for Anaplastic Oligodendroglioma  Academic Article
• High-dose chemotherapy with stem cell rescue as initial therapy for anaplastic oligodendroglioma: Long-term follow-up  Academic Article
• Hospital and home chemotherapy for children with leukemia: A randomized cross-over study  Academic Article
• Hypomagnesemia associated with chemotherapy in patients treated for acute lymphoblastic leukemia: Possible mechanisms  Academic Article
• Ibrutinib combined with bendamustine and rituximab compared with placebo, bendamustine, and rituximab for previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (HELIOS): a randomised, double-blind, phase 3 study  Academic Article
• Identification of Cancer Care and Protocol Characteristics Associated With Recruitment in Breast Cancer Clinical Trials  Academic Article
• Identification of Chemotherapy-Induced Leukemic-Regenerating Cells Reveals a Transient Vulnerability of Human AML Recurrence  Academic Article
• Ifosfamide and mesna in combination with other cytostatic drugs in the treatment of patients with advanced cancer  Academic Article
• Imaging, procedural and clinical variables associated with tumor yield on bone biopsy in metastatic castration-resistant prostate cancer  Academic Article
• Immediate Versus Delayed Access of Implantable Venous Access Devices: Does the Timing of Access Make a Difference to the Frequency of Complications?  Academic Article
• Immune Checkpoint Inhibitors for Patients With Advanced Non–Small-Cell Lung Cancer: A Systematic Review  Academic Article
• Impact of CYP19A1 and ESR1 variants on early-onset side effects during combined endocrine therapy in the TEXT trial  Academic Article
• Impact of Chemotherapy on Thrombin Generation and on the Protein C Pathway in Breast Cancer Patients  Academic Article
• Impact of registration on clinical trials on infection risk in pediatric acute myeloid leukemia  Academic Article
• Impact of the addition of chemotherapy to radiotherapy for oropharyngeal cancer in 2003-2004: Population-based study from the Province of Ontario, Canada  Academic Article
• Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01  Academic Article
• Incidence and Prognostic Impact of Amenorrhea During Adjuvant Therapy in High-Risk Premenopausal Breast Cancer: Analysis of a National Cancer Institute of Canada Clinical Trials Group Study—NCIC CTG MA.5  Academic Article
• Incidence, Risk Factors, and Outcomes of Catheter-Related Thrombosis in Adult Patients With Cancer  Academic Article
• Increased thromboembolic complications with concurrent tamoxifen and chemotherapy in a randomized trial of adjuvant therapy for women with breast cancer. National Cancer Institute of Canada Clinical Trials Group Breast Cancer Site Group.  Academic Article
• Induction failure in acute lymphoblastic leukemia of childhood  Academic Article
• Inhibiting STAT3 in a murine model of human breast cancer-induced bone pain delays the onset of nociception  Academic Article
• Inhibition of fibroblast to myofibroblast transition by halofuginone contributes to the chemotherapy-mediated antitumoral effect  Academic Article
• Inhibition of the colony-stimulating-factor-1 receptor affects the resistance of lung cancer cells to cisplatin  Academic Article
• Integration of autologous dendritic cell-based immunotherapy in the primary treatment for patients with newly diagnosed glioblastoma multiforme: a pilot study  Academic Article
• Intensive remission consolidation therapy in the treatment of acute nonlymphocytic leukemia.  Academic Article
• Interactions of doxycycline with chemotherapeutic agents in human breast adenocarcinoma MDA-MB-231 cells  Academic Article
• Interleukin-1 beta expression and treatment outcome in acute myelogenous leukemia [letter]  Academic Article
• Is there convincing evidence for the use of chemotherapy alone in patients with limited stage Hodgkin's lymphoma?  Academic Article
• Lack of correlation of P-glycoprotein expression with response to MIC chemotherapy in oesophageal cancer.  Academic Article
• Lacosamide as add-on in brain tumor-related epilepsy: preliminary report on efficacy and tolerability  Academic Article
• Lapatinib or Trastuzumab Plus Taxane Therapy for Human Epidermal Growth Factor Receptor 2–Positive Advanced Breast Cancer: Final Results of NCIC CTG MA.31  Academic Article
• Lapatinib-Related Rash and Breast Cancer Outcome in the ALTTO Phase III Randomized Trial  Academic Article
• Lenalidomide Plus Melphalan Without Prednisone for Previously Untreated Older Patients With Multiple Myeloma: A Phase II Trial  Academic Article
• Leukapheresis and low-dose chemotherapy do not reduce early mortality in acute myeloid leukemia hyperleukocytosis: A systematic review and meta-analysis  Academic Article
• Limited-Stage Hodgkin Lymphoma: Managing Uncertainty  Academic Article
• Liver resection after chemotherapy and tumour downsizing in patients with initially unresectable colorectal cancer liver metastases  Academic Article
• Locally advanced breast cancer in octogenarian women  Academic Article
• Long-term hazard of recurrence in HER2+ breast cancer patients untreated with anti-HER2 therapy  Academic Article
• Long-term outcome of a pediatric-inspired regimen used for adults aged 18–50 years with newly diagnosed acute lymphoblastic leukemia  Academic Article
• Long-term outcomes to fludarabine and rituximab in Waldenström macroglobulinemia  Academic Article
• Long-term results of Dana-Farber Cancer Institute ALL Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1985–2000)  Academic Article
• Long-term results of a pilot study for the treatment of advanced unresectable head and neck tumors by combination chemotherapy and split course radiotherapy.  Academic Article
• Long-term survival following extra-neural metastasis from a pineoblastoma.  Academic Article
• Low Molecular Weight Heparin, Therapy With Dalteparin, and Survival in Advanced Cancer: The Fragmin Advanced Malignancy Outcome Study (FAMOUS)  Academic Article
• Low-grade serous carcinoma (LGSC): A Canadian multicenter review of practice patterns and patient outcomes  Conference Paper
• Lung cancer chemotherapy agents increase procoagulant activity via protein disulfide isomerase-dependent tissue factor decryption  Academic Article
• Malignant Pleural Mesothelioma  Academic Article
• Management of Children with Acute Lymphoblastic Leukemia by the Dana-Farber Cancer Institute Protocols  Academic Article
• Management of Ontario children with acute lymphoblastic leukemia by the Dana-Farber Cancer Institute protocols.  Academic Article
• Management of advanced or recurrent cervical cancer: chemotherapy and beyond  Academic Article
• Management of unresected stage III non-small cell lung cancer: a systematic review.  Academic Article
• Margetuximab plus pembrolizumab in patients with previously treated, HER2-positive gastro-oesophageal adenocarcinoma (CP-MGAH22–05): a single-arm, phase 1b–2 trial  Academic Article
• Megestrol acetate plus minidose diethylstilbestrol in the treatment of carcinoma of the prostate.  Academic Article
• Melena: a rare presentation of childhood Burkitt's lymphoma  Academic Article
• Metastatic Merkel cell tumor to the prostate and bladder  Academic Article
• Method to Our Madness or Madness in Our Methods? Pitfalls in Trial Methodology  Academic Article
• Methotrexate/fluorouracil scheduling influences normal tissue toxicity but not antitumor effects in patients with squamous cell head and neck cancer: results from a randomized trial.  Academic Article
• Mineral homeostasis and bone mass in children treated for acute lymphoblastic leukemia  Academic Article
• Modified adriamycin-vincristine-dexamethasone (m-VAD) in primary refractory and relapsed plasma cell myeloma: an NCI (Canada) pilot study. The National Cancer Institute of Canada Clinical Trials Group.  Academic Article
• Modulation of the antitumor effect of methotrexate by low-dose leucovorin in squamous cell head and neck cancer: a randomized placebo-controlled clinical trial.  Academic Article
• More Evidence That Locoregional Radiation Therapy Improves Survival: What Should We Do?  Academic Article
• NCCN Task Force Report: Adjuvant Therapy for Breast Cancer.  Academic Article
• NCIC CTG IND.190 Phase I Trial of Dalotuzumab (MK-0646) in Combination with Cisplatin and Etoposide in Extensive-Stage Small-Cell Lung Cancer  Academic Article
• Natural History and Chemotherapy Effectiveness for Advanced Adenocarcinoma of the Small Bowel: A Retrospective Review of 113 Cases  Academic Article
• Neoadjuvant Gemcitabine Chemotherapy followed by Concurrent IMRT Simultaneous Boost Achieves High R0 Resection in Borderline Resectable Pancreatic Cancer Patients  Academic Article
• Neoadjuvant or adjuvant therapy for resectable gastric cancer: a systematic review and practice guideline for North America  Academic Article
• Neonatal Hepatoblastoma: Two Cases Posing a Diagnostic Dilemma, with a Review of the Literature  Academic Article
• Network meta-analysis of therapies for previously untreated advanced BRAF-mutated melanoma  Academic Article
• Neuropsychological Outcomes From a Randomized Trial of Triple Intrathecal Chemotherapy Compared With 18 Gy Cranial Radiation As CNS Treatment in Acute Lymphoblastic Leukemia: Findings From Dana-Farber Cancer Institute ALL Consortium Protocol 95-01  Academic Article
• Neuropsychological late effects of treatment for acute leukemia in children with Down syndrome  Academic Article
• Neutropenia as a Potential Pharmacodynamic Marker for Docetaxel-Based Chemotherapy in Men With Metastatic Castration-Resistant Prostate Cancer  Academic Article
• New therapeutic strategies to treat human cancers expressing mutant p53 proteins  Academic Article
• Nivolumab in Combination With Platinum‐Based Doublet Chemotherapy for First-Line Treatment of Advanced Non–Small-Cell Lung Cancer  Academic Article
• Nivolumab plus ipilimumab as first-line treatment for advanced non-small-cell lung cancer (CheckMate 012): results of an open-label, phase 1, multicohort study  Academic Article
• Nomograms to Predict Serious Adverse Events in Phase II Clinical Trials of Molecularly Targeted Agents  Academic Article
• OSTEOSARCOMA AND PULMONARY METASTASES: 15-YEAR EXPERIENCE FROM A SINGLE INSTITUTION  Academic Article
• Obstructive jaundice caused by neuroblastoma managed with temporary cholecystostomy tube  Academic Article
• Octreotide LAR and tamoxifen versus tamoxifen in phase III randomize early breast cancer trials: NCIC CTG MA.14 and NSABP B-29  Academic Article
• Offering a choice between two adjuvant chemotherapy regimens: a pilot study to develop a decision aid for women with breast cancer  Conference Paper
• Oligodendroglioma  Academic Article
• Ondansetron Compared with Dexamethasone and Metoclopramide as Antiemetics in the Chemotherapy of Breast Cancer with Cyclophosphamide, Methotrexate, and Fluorouracil  Academic Article
• Opinions in pediatric and adolescent gynecology  Academic Article
• Optimal Chemotherapy for Women With Breast Cancer: The Plot Thickens  Academic Article
• Optimal Duration of Extended Adjuvant Endocrine Therapy for Early Breast Cancer; Results of the IDEAL Trial (BOOG 2006-05)  Academic Article
• Optimizing Anticancer Therapy in Metastatic Non-Castrate Prostate Cancer: American Society of Clinical Oncology Clinical Practice Guideline  Academic Article
• Osteopenia in children with acute lymphoblastic leukemia: A pilot study of amelioration with pamidronate  Academic Article
• Outcome of children and adolescents with Down syndrome treated on Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium protocols 00-001 and 05-001  Academic Article
• Outcomes in Patients With Clinical Stage III NSGCT Who Achieve Complete Clinical Response to Chemotherapy at Extraretroperitoneal Disease Site  Academic Article
• Outcomes in patients with advanced urothelial carcinoma after discontinuation of programmed death (PD)-1 or PD ligand 1 inhibitor therapy  Academic Article
• Outcomes of MYC-associated lymphomas after R-CHOP with and without consolidative autologous stem cell transplant: subset analysis of randomized trial intergroup SWOG S9704  Academic Article
• Ovarian ablation as adjuvant therapy for early-stage breast cancer  Academic Article
• Ovarian cancer in elderly patients: carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in late relapse: a Gynecologic Cancer Intergroup (GCIG) CALYPSO sub-study  Academic Article
• Ovarian suppression/ablation in premenopausal ER-positive breast cancer patients. Issues and recommendations.  Academic Article
• Overstated Conclusions of a Pooled Analysis of Bevacizumab in Colon Cancer  Academic Article
• PANCREOX: A Randomized Phase III Study of Fluorouracil/Leucovorin With or Without Oxaliplatin for Second-Line Advanced Pancreatic Cancer in Patients Who Have Received Gemcitabine-Based Chemotherapy  Academic Article
• PML/RARα APL with undifferentiated morphology and stem cell immunophenotype  Academic Article
• Paclitaxel and bevacizumab with or without capecitabine as first-line treatment for HER2-negative locally recurrent or metastatic breast cancer: A multicentre, open-label, randomised phase 2 trial  Academic Article
• Paclitaxel and cisplatin as intravesical agents against non-muscle-invasive bladder cancer  Academic Article
• Palbociclib in hormone receptor positive advanced breast cancer: A cost-utility analysis  Academic Article
• Paraspinal Synovial Sarcoma as an Unusual Postradiation Complication in Pediatric Abdominal Neuroblastoma  Academic Article
• Patients’ Preferences for Therapy in Advanced Epithelial Ovarian Cancer: Development, Testing, and Application of a Bedside Decision Instrument  Academic Article
• Patterns of disease progression and outcomes in a randomized trial testing ABVD alone for patients with limited-stage Hodgkin lymphoma  Academic Article
• Pegylated Liposomal Doxorubicin and Trastuzumab in HER-2 Overexpressing Metastatic Breast Cancer: A Multicenter Phase II Trial  Conference Paper
• Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial  Academic Article
• Perioperative DCF chemotherapy protocol for patients with gastroesophageal adenocarcinoma: correlation between response to treatment and outcome  Academic Article
• Perioperative docetaxel, cisplatin, and 5-fluorouracil (DCF) for locally advanced esophageal and gastric adenocarcinoma: a multicenter phase II trial  Academic Article
• Pharmacoeconomics of Systemic Therapies for Lung Cancer  Academic Article
• Pharmacokinetic interaction between taxanes and amiodarone leading to severe toxicity  Academic Article
• Pharmacokinetics, Safety, and Efficacy of Trastuzumab Administered Every Three Weeks in Combination With Paclitaxel  Academic Article
• Phase 1/2 Study of the CD56-Targeting Antibody-Drug Conjugate Lorvotuzumab Mertansine (IMGN901) in Combination With Carboplatin/Etoposide in Small-Cell Lung Cancer Patients With Extensive-Stage Disease  Academic Article
• Phase 2 Study of Erlotinib in Combination With Linsitinib (OSI-906) or Placebo in Chemotherapy-Naive Patients With Non–Small-Cell Lung Cancer and Activating Epidermal Growth Factor Receptor Mutations  Academic Article
• Phase I Clinical and Pharmacokinetic Study of Pemetrexed and Carboplatin in Patients With Malignant Pleural Mesothelioma  Academic Article
• Phase I Dose-Escalation Study of Linsitinib (OSI-906) and Erlotinib in Patients with Advanced Solid Tumors  Academic Article
• Phase I Open-Label Study of Continuous Treatment with BIBF 1120, a Triple Angiokinase Inhibitor, and Pemetrexed in Pretreated Non–Small Cell Lung Cancer Patients  Academic Article
• Phase I Study of Combination Topotecan and Carboplatin in Pediatric Solid Tumors  Academic Article
• Phase I Study of Decitabine in Combination with Vorinostat in Patients with Advanced Solid Tumors and Non-Hodgkin's Lymphomas  Academic Article
• Phase I Targeted Combination Trial of Sorafenib and Erlotinib in Patients with Advanced Solid Tumors  Academic Article
• Phase I Trial of Granulocyte-Macrophage Colony-Stimulating Factor With High-Dose Cisplatin and Etoposide for Treatment of Small-Cell Lung Cancer: A Study of the National Cancer Institute of Canada Clinical Trials Group  Academic Article
• Phase I Trial of the Matrix Metalloproteinase Inhibitor Marimastat Combined with Carboplatin and Paclitaxel in Patients with Advanced Non–Small Cell Lung Cancer  Academic Article
• Phase I and Pharmacokinetic Study of Daily Oral AZD2171, an Inhibitor of Vascular Endothelial Growth Factor Tyrosine Kinases, in Combination With Carboplatin and Paclitaxel in Patients With Advanced Non–Small-Cell Lung Cancer: The National Cancer Institute of Canada Clinical Trials Group  Academic Article
• Phase I studies of fluorouracil, doxorubicin and vinorelbine without (FAN) and with (SUPERFAN) folinic acid in patients with advanced breast cancer  Academic Article
• Phase I study of Tomudex and Doxorubicin in patients with locally advanced, inoperable or metastatic cancer (IND.98)  Academic Article
• Phase I study of vinblastine and temsirolimus in pediatric patients with recurrent or refractory solid tumors: Canadian Cancer Trials Group Study IND.218  Academic Article
• Phase I trial of UCN-01 in combination with topotecan in patients with advanced solid cancers: a Princess Margaret Hospital Phase II Consortium study  Academic Article
• Phase I trial of gemcitabine, doxorubicin and cisplatin (GAP) in patients with advanced solid tumors  Academic Article
• Phase I/II Study of Pemetrexed With or Without ABT-751 in Advanced or Metastatic Non–Small-Cell Lung Cancer  Academic Article
• Phase I/II Trial of Erlotinib and Cisplatin in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: A Princess Margaret Hospital Phase II Consortium and National Cancer Institute of Canada Clinical Trials Group Study  Conference Paper
• Phase I/II Trial of Metronomic Chemotherapy With Daily Dalteparin and Cyclophosphamide, Twice-Weekly Methotrexate, and Daily Prednisone As Therapy for Metastatic Breast Cancer Using Vascular Endothelial Growth Factor and Soluble Vascular Endothelial Growth Factor Receptor Levels As Markers of Response  Academic Article
• Phase II Study of Sequential Topotecan and Etoposide in Patients with Intermediate Grade Non-Hodgkin's Lymphoma: A National Cancer Institute of Canada Clinical Trials Group Study  Academic Article
• Phase II Trial of 13-cis-Retinoic Acid Plus Interferon   in Non-Small-Cell Lung Cancer: For the National Cancer Instit ute of Canada Clinical Trials Group  Academic Article
• Phase II Trial of OGX-011 in Combination with Docetaxel in Metastatic Breast Cancer  Academic Article
• Phase II Trial of Preoperative Chemoradiation in Patients With Localized Gastric Adenocarcinoma (RTOG 9904): Quality of Combined Modality Therapy and Pathologic Response  Academic Article
• Phase II clinical trial of carboplatin and docetaxel in patients with metastatic ovarian cancer: Active combination with low incidence of peripheral neuropathy  Academic Article
• Phase II multicenter study of oblimersen sodium, a Bcl-2 antisense oligonucleotide, in combination with rituximab in patients with recurrent B-cell non-Hodgkin lymphoma  Academic Article
• Phase II study of mitomycin C and 5 fluorouracil in platinum resistant ovarian cancer.  Academic Article
• Phase II study of pegylated liposomal doxorubicin HCl (Caelyx) in combination with cyclophosphamide and vincristine as second-line treatment of patients with small cell lung cancer  Academic Article
• Phase II study of pemetrexed disodium, a multitargeted antifolate, and cisplatin as first-line therapy in patients with advanced nonsmall cell lung carcinoma  Academic Article
• Phase III Comparative Study of Vinorelbine Combined With Doxorubicin Versus Doxorubicin Alone in Disseminated Metastatic/Recurrent Breast Cancer: National Cancer Institute of Canada Clinical Trials Group Study MA8  Academic Article
• Phase III Study of N,N-Diethyl-2-[4-(Phenylmethyl) Phenoxy]Ethanamine (BMS-217380-01) Combined With Doxorubicin Versus Doxorubicin Alone in Metastatic/Recurrent Breast Cancer: National Cancer Institute of Canada Clinical Trials Group Study MA.19  Academic Article
• Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma  Academic Article
• Phosphoinositide 3-kinase inhibitors in advanced breast cancer: A systematic review and meta-analysis  Academic Article
• Photodynamic therapy using Photofrin in combination with buthionine sulfoximine (BSO) to treat 9L gliosarcoma in rat brain  Academic Article
• Physical Activity in Long-term Survivors of Acute Lymphoblastic Leukemia in Childhood and Adolescence  Academic Article
• Pilot studies of superfractionated radiotherapy and combination chemotherapy in limited oat cell carcinoma of the bronchus  Academic Article
• Platinum-based chemotherapy in triple-negative advanced breast cancer  Academic Article
• Point/counterpoint: early-stage Hodgkin lymphoma and the role of radiation therapy  Academic Article
• Postmenopausal breast cancer: is the short-term pain worth the long-term gain?  Academic Article
• Posttreatment prognostic nomogram for patients with metastatic urothelial cancer completing first-line cisplatin-based chemotherapy  Academic Article
• Practice guideline for the role of combination chemotherapy in the initial management of limited-stage small-cell lung cancer  Academic Article
• Pre-operative bevacizumab, capecitabine, oxaliplatin and radiation among patients with locally advanced or low rectal cancer: A phase II trial  Academic Article
• Predicting Anthracycline Benefit: TOP2A and CEP17—Not Only but Also  Academic Article
• Prediction of response of patients with acute nonlymphocytic leukaemia to remission induction therapy: use of clinical measurements  Academic Article
• Predictors of bony morbidity in children with acute lymphoblastic leukemia  Academic Article
• Preoperative or Postoperative Therapy for Stage II or III Rectal Cancer: An Updated Practice Guideline  Academic Article
• Prognostic Impact of the Neutrophil-to-Lymphocyte Ratio in Men With Metastatic Castration-Resistant Prostate Cancer  Academic Article
• Prognostic and predictive investigation of PAM50 intrinsic subtypes in the NCIC CTG MA.21 phase III chemotherapy trial  Academic Article
• Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial  Academic Article
• Prognostic associations of 25 hydroxy vitamin D in NCIC CTG MA.21, a phase III adjuvant randomized clinical trial of three chemotherapy regimens in high-risk breast cancer  Academic Article
• Prognostic factors in patients with small-cell carcinoma of the lung.  Academic Article
• Prognostic risk stratification derived from individual patient level data for men with advanced penile squamous cell carcinoma receiving first-line systemic therapy  Academic Article
• Prognostic value of early response to chemotherapy assessed by the day 15 bone marrow aspiration in adult acute lymphoblastic leukemia: A prospective analysis of 437 cases and its application for designing induction chemotherapy trials  Academic Article
• Prophylactic Granulocyte Colony-Stimulating Factor and Granulocyte-Macrophage Colony-Stimulating Factor Decrease Febrile Neutropenia After Chemotherapy in Children With Cancer: A Meta-Analysis of Randomized Controlled Trials  Academic Article
• Prospective Evaluation of the 21-Gene Recurrence Score Assay for Breast Cancer Decision-Making in Ontario  Academic Article
• Prospective Validation of a 21-Gene Expression Assay in Breast Cancer  Academic Article
• Prospective randomized trial of one-hour sequential versus simultaneous methotrexate plus 5-fluorouracil in advanced and recurrent squamous cell head and neck cancer.  Academic Article
• Protocol-based treatment for children with cancer in low income countries in Latin America: A report on the recent meetings of the Monza International School of Pediatric Hematology/Oncology (MISPHO)-Part II  Academic Article
• Pulmonary lymphangiomyomatosis complicating pregnancy. A case report.  Academic Article
• Pyomyositis Causing Temporary Quadriparesis During Induction Therapy for Acute Lymphoblastic Leukemia  Academic Article
• Quality of Life Analyses in a Clinical Trial of DPPE (tesmilifene) Plus Doxorubicin Versus Doxorubicin in Patients with Advanced or Metastatic Breast Cancer: NCIC CTG Trial MA.19  Academic Article
• Radiation in early-stage Hodgkin lymphoma.  Academic Article
• Radiographic progression by Prostate Cancer Working Group (PCWG)-2 criteria as an intermediate endpoint for drug development in metastatic castration-resistant prostate cancer  Academic Article
• Radiotherapy and adjuvant chemotherapy for childhood medulloblastoma. The Royal Marsden Hospital experience.  Academic Article
• Radiotherapy to control CNS lymphomatoid granulomatosis: A case report and review of the literature  Academic Article
• Randomised, double-blind trial of carboplatin and paclitaxel with daily oral cediranib or placebo in patients with advanced non-small cell lung cancer: NCIC Clinical Trials Group study BR29  Academic Article
• Randomised, phase II, placebo-controlled, trial of fulvestrant plus vandetanib in postmenopausal women with bone only or bone predominant, hormone-receptor-positive metastatic breast cancer (MBC): the OCOG ZAMBONEY study  Academic Article
• Randomized Comparison of ABVD Chemotherapy With a Strategy That Includes Radiation Therapy in Patients With Limited-Stage Hodgkin’s Lymphoma: National Cancer Institute of Canada Clinical Trials Group and the Eastern Cooperative Oncology Group  Academic Article
• Randomized Comparison of Gemcitabine, Dexamethasone, and Cisplatin Versus Dexamethasone, Cytarabine, and Cisplatin Chemotherapy Before Autologous Stem-Cell Transplantation for Relapsed and Refractory Aggressive Lymphomas: NCIC-CTG LY.12  Academic Article
• Randomized Phase II Study of Docetaxel and Prednisone With or Without OGX-011 in Patients With Metastatic Castration-Resistant Prostate Cancer  Conference Paper
• Randomized Phase II Study of Gemcitabine Plus Cisplatin or Carboplatin, With or Without Cetuximab, As First-Line Therapy for Patients With Advanced or Metastatic Non–Small-Cell Lung Cancer  Conference Paper
• Randomized Phase II Trial of Custirsen (OGX-011) in Combination with Docetaxel or Mitoxantrone as Second-line Therapy in Patients with Metastatic Castrate-Resistant Prostate Cancer Progressing after First-line Docetaxel: CUOG Trial P-06c  Academic Article
• Randomized Phase III Study of Fludarabine Phosphate Versus Cyclophosphamide, Vincristine, and Prednisone in Patients With Recurrent Low-Grade Non-Hodgkin’s Lymphoma Previously Treated With an Alkylating Agent or Alkylator-Containing Regimen  Academic Article
• Randomized Phase III Study of Matrix Metalloproteinase Inhibitor BMS-275291 in Combination With Paclitaxel and Carboplatin in Advanced Non-Small-Cell Lung Cancer: National Cancer Institute of Canada-Clinical Trials Group Study BR.18  Academic Article
• Randomized Phase III Trial Comparing Irinotecan/Cisplatin With Etoposide/Cisplatin in Patients With Previously Untreated Extensive-Stage Disease Small-Cell Lung Cancer  Conference Paper
• Randomized Trial Comparing Cyclophosphamide, Epirubicin, and Fluorouracil With Cyclophosphamide, Methotrexate, and Fluorouracil in Premenopausal Women With Node-Positive Breast Cancer: Update of National Cancer Institute of Canada Clinical Trials Group Trial MA5  Academic Article
• Randomized Trial of High-Dose Chemotherapy With Autologous Peripheral-Blood Stem-Cell Support Compared With Standard-Dose Chemotherapy in Women With Metastatic Breast Cancer: NCIC MA.16  Academic Article
• Randomized Trial of Letrozole Following Tamoxifen as Extended Adjuvant Therapy in Receptor-Positive Breast Cancer: Updated Findings from NCIC CTG MA.17  Academic Article
• Randomized Trial of Tamoxifen Versus Combined Tamoxifen and Octreotide LAR Therapy in the Adjuvant Treatment of Early-Stage Breast Cancer in Postmenopausal Women: NCIC CTG MA.14  Academic Article
• Randomized phase II comparison of standard CHOP with weekly CHOP in elderly patients with non-Hodgkin's lymphoma.  Academic Article
• Randomized phase II feasibility study of combining the matrix metalloproteinase inhibitor BMS-275291 with paclitaxel plus carboplatin in advanced non-small cell lung cancer  Academic Article
• Randomized phase II study of modified FOLFOX-6 in combination with ramucirumab or icrucumab as second-line therapy in patients with metastatic colorectal cancer after disease progression on first-line irinotecan-based therapy  Academic Article
• Randomized trial of cyclophosphamide, methotrexate, and fluorouracil chemotherapy added to tamoxifen as adjuvant therapy in postmenopausal women with node-positive estrogen and/or progesterone receptor-positive breast cancer: a report of the National Cancer Institute of Canada Clinical Trials Group. Breast Cancer Site Group.  Academic Article
• Randomized trial of intensive cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer. National Cancer Institute of Canada Clinical Trials Group.  Academic Article
• Randomized trial of interferon maintenance in multiple myeloma: a study of the National Cancer Institute of Canada Clinical Trials Group.  Academic Article
• Randomized, Double-Blind Trial of Carboplatin and Paclitaxel With Either Daily Oral Cediranib or Placebo in Advanced Non–Small-Cell Lung Cancer: NCIC Clinical Trials Group BR24 Study  Academic Article
• Randomized, Placebo-Controlled, Phase III Study of First-Line Oxaliplatin-Based Chemotherapy Plus PTK787/ZK 222584, an Oral Vascular Endothelial Growth Factor Receptor Inhibitor, in Patients With Metastatic Colorectal Adenocarcinoma  Academic Article
• Randomized, double-blind, placebo-controlled trial comparing the response rates of carmustine, dacarbazine, and cisplatin with and without tamoxifen in patients with metastatic melanoma. National Cancer Institute of Canada Clinical Trials Group.  Academic Article
• Reduction in serum clusterin is a potential therapeutic biomarker in patients with castration‐resistant prostate cancer treated with custirsen  Academic Article
• Relapse-free survival of statistically standardized continuous RT-PCR estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2): NCIC CTG MA.14  Academic Article
• Relation between platinum-DNA adducts and complete remission in adult acute nonlymphocytic leukemia  Academic Article
• Relationship between the per cent of marrow cells in S phase and the outcome of remission-induction therapy for acute nonlymphocytic leukaemia  Academic Article
• Remissions after third induction chemotherapy for primary non-responders with acute myeloid leukemia (AML) are uncommon and short-lived  Academic Article
• Responsiveness of Intrinsic Subtypes to Adjuvant Anthracycline Substitution in the NCIC.CTG MA.5 Randomized Trial  Academic Article
• Results of a Multicenter Randomized Phase II Trial of Thalidomide and Prednisone Maintenance Therapy for Multiple Myeloma after Autologous Stem Cell Transplant  Academic Article
• Risk of Acute Leukemia Following Epirubicin-Based Adjuvant Chemotherapy: A Report From the National Cancer Institute of Canada Clinical Trials Group  Academic Article
• Risk of Menopause During the First Year After Breast Cancer Diagnosis  Academic Article
• Risk of Premature Menopause After Treatment for Hodgkin's Lymphoma  Academic Article
• Rolapitant improves quality of life of patients receiving highly or moderately emetogenic chemotherapy  Academic Article
• Role of Gonadotropin-Releasing Hormone Analog in the Management of Male Metastatic Breast Cancer Is Uncertain  Academic Article
• Safety Analysis of Four Randomized Controlled Studies of Ibrutinib in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Mantle Cell Lymphoma  Academic Article
• Safety and Efficacy of Everolimus With Exemestane vs. Exemestane Alone in Elderly Patients With HER2-Negative, Hormone Receptor–Positive Breast Cancer in BOLERO-2  Academic Article
• Safety of Treatment of Metastatic Breast Cancer With Trastuzumab Beyond Disease Progression  Academic Article
• Safety of bevacizumab in metastatic breast cancer patients undergoing surgery  Academic Article
• Salvage chemotherapy and autologous stem cell transplantation for peripheral T-cell lymphoma: a subset analysis of the Canadian Cancer Trials Group LY.12 randomized phase 3 study  Academic Article
• Salvage chemotherapy and autologous stem cell transplantation for transformed indolent lymphoma: a subset analysis of NCIC CTG LY12  Academic Article
• Salvage surgery after induction chemotherapy with paclitaxel/cisplatin and primary radiotherapy for advanced laryngeal and hypopharyngeal carcinomas  Academic Article
• Second-line chemotherapy of stage III-IV ovarian carcinoma: a randomized comparison of melphalan to melphalan and hexamethylmelamine in patients with persistent disease after doxorubicin and cisplatin.  Academic Article
• Second-line or Subsequent Systemic Therapy for Recurrent or Progressive Non-Small Cell Lung Cancer: A Systematic Review and Practice Guideline  Academic Article
• Selection of adjuvant chemotherapy for treatment of node-positive breast cancer  Academic Article
• Selumetinib in patients receiving standard pemetrexed and platinum-based chemotherapy for advanced or metastatic KRAS wildtype or unknown non-squamous non-small cell lung cancer: A randomized, multicenter, phase II study. Canadian Cancer Trials Group (CCTG) IND.219  Academic Article
• Serotonin transporter antagonists target tumor-initiating cells in a transgenic mouse model of breast cancer  Academic Article
• Serum alkaline phosphatase changes predict survival independent of PSA changes in men with castration-resistant prostate cancer and bone metastasis receiving chemotherapy  Academic Article
• Should platinum-based chemotherapy be preferred for germline BReast CAncer genes (BRCA) 1 and 2-mutated pancreatic ductal adenocarcinoma (PDAC) patients? A systematic review and meta-analysis  Academic Article
• Side effects associated with the use of dexamethasone for prophylaxis of delayed emesis after moderately emetogenic chemotherapy  Academic Article
• Significance of Co-expression of Epidermal Growth Factor Receptor and Ki67 on Clinical Outcome in Patients With Anal Cancer Treated With Chemoradiotherapy: An Analysis of NRG Oncology RTOG 9811  Conference Paper
• Single-agent Taxane Versus Taxane-containing Combination Chemotherapy as Salvage Therapy for Advanced Urothelial Carcinoma.  Academic Article
• Skeletal Morbidity in Childhood Acute Lymphoblastic Leukemia  Academic Article
• Sorafenib in Combination With Gemcitabine in Recurrent Epithelial Ovarian Cancer: A Study of the Princess Margaret Hospital Phase II Consortium  Academic Article
• Spindle epithelial tumor with thymus-like elements of the thyroid: a multi-institutional case series and review of the literature  Academic Article
• Standard chemotherapy with or without bevacizumab in advanced ovarian cancer: quality-of-life outcomes from the International Collaboration on Ovarian Neoplasms (ICON7) phase 3 randomised trial  Academic Article
• Statin therapy in the treatment of active cancer: A systematic review and meta-analysis of randomized controlled trials  Academic Article
• Successful treatment of neonatal trilateral retinoblastoma  Academic Article
• Superiority of Alternating Non-Cross-Resistant Chemotherapy in Extensive Small Cell Lung Cancer  Academic Article
• Superiority of Granisetron to Dexamethasone Plus Prochlorperazine in the Prevention of Chemotherapy-Induced Emesis  Academic Article
• Supplementation with fish oil increases first-line chemotherapy efficacy in patients with advanced nonsmall cell lung cancer  Academic Article
• Surgery as sole treatment for serous borderline tumors of the ovary with noninvasive implants  Academic Article
• Survival and PSA response of patients in the TAX 327 study who crossed over to receive docetaxel after mitoxantrone or vice versa  Academic Article
• Survival results from a phase III study of simultaneous versus 1-hour sequential methotrexate—5-fluorouracil chemotherapy in head and neck cancer  Academic Article
• Systemic Adjuvant Therapy for Node-Negative Breast Cancer: Proven or Premature?  Academic Article
• Systemic Exposure of Rituximab Increased by Ibrutinib: Pharmacokinetic Results and Modeling Based on the HELIOS Trial  Academic Article
• Systemic Therapy for Previously Untreated Advanced BRAF-Mutated Melanoma  Academic Article
• Systemic Therapy in Men with Metastatic Castration-resistant Prostate Cancer: A Systematic Review  Academic Article
• Systemic adjuvant therapy for adult patients at high risk for recurrent melanoma: A systematic review  Academic Article
• Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Early Breast Cancer Trialists' Collaborative Group.  Academic Article
• TIMP-1 in combination with HER2 and TOP2A for prediction of benefit from adjuvant anthracyclines in high-risk breast cancer patients  Academic Article
• Tailored targeted therapy for all: a realistic and worthwhile objective against  Academic Article
• Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015  Academic Article
• Tamoxifen and conjugated estrogens (Premarin) followed by sequenced methotrexate and 5-FU in refractory advanced breast cancer.  Academic Article
• Targeting the epidermal growth factor receptor in non-small-cell lung cancer: Who, which, when, and how?  Academic Article
• Taxanes as first-line therapy for advanced non-small cell lung cancer: A systematic review and practice guideline  Academic Article
• Temsirolimus in combination with carboplatin and paclitaxel in patients with advanced solid tumors: a NCIC-CTG, phase I, open-label dose-escalation study (IND 179)  Academic Article
• Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma  Academic Article
• Thalidomide-prednisone maintenance following autologous stem cell transplant for Multiple Myeloma: effect on thrombin generation and procoagulant markers in NCIC CTG MY.10  Academic Article
• The CDK inhibitor AT7519M in patients with relapsed or refractory chronic lymphocytic leukemia (CLL) and mantle cell lymphoma. A Phase II study of the Canadian Cancer Trials Group  Academic Article
• The Canadian Experience with Intensive Fluorouracil, Epirubicin and Cyclophosphamide in Patients with Early Stage Breast Cancer  Academic Article
• The Clinical Activity of PD-1/PD-L1 Inhibitors in Metastatic Non–Clear Cell Renal Cell Carcinoma  Academic Article
• The Impact of Adding Taxanes to Gemcitabine and Platinum Chemotherapy for the First-Line Therapy of Advanced or Metastatic Urothelial Cancer: A Systematic Review and Meta-analysis  Academic Article
• The Role of Gemcitabine in the Treatment of Cholangiocarcinoma and Gallbladder Cancer: A Systematic Review  Academic Article
• The Role of High-Dose Chemotherapy and Stem-Cell Transplantation in Patients with Multiple Myeloma: A Practice Guideline of the Cancer Care Ontario Practice Guidelines Initiative  Academic Article
• The Thrombogenic Effect of Anticancer Drug Therapy in Women with Stage II Breast Cancer  Academic Article
• The Thrombospondin-1 Mimetic ABT-510 Increases the Uptake and Effectiveness of Cisplatin and Paclitaxel in a Mouse Model of Epithelial Ovarian Cancer  Academic Article
• The association between population-based treatment guidelines and adjuvant therapy for node-negative breast cancer  Academic Article
• The development of thromboembolism may increase the risk of osteonecrosis in children with acute lymphoblastic leukemia  Academic Article
• The effect of systemic adjuvant chemotherapy on local breast recurrence in node positive breast cancer patients treated by lumpectomy without radiation  Academic Article
• The evidence for tamoxifen and chemotherapy as treatment for metastatic melanoma  Academic Article
• The histone deacetylase inhibitor valproic acid alters sensitivity towards all trans retinoic acid in acute myeloblastic leukemia cells  Academic Article
• The impact of postchemotherapy nausea and vomiting on quality of life after moderately emetogenic chemotherapy  Academic Article
• The rapid uptake of concurrent chemotherapy for cervix cancer patients treated with curative radiation  Conference Paper
• The role of dose intensity in determining outcome in intermediate-grade non-Hodgkin's lymphoma.  Academic Article
• The selective use of AMSA following high-dose cytarabine in patients with acute myeloid leukaemia in relapse: a Leukemia Intergroup Study  Academic Article
• The treatment of patients with acute nonlymphocytic leukemia in remission.  Academic Article
• The treatment of patients with newly diagnosed poor prognosis acute myelogenous leukaemia: response to treatment and treatment failure  Academic Article
• The use of VP-16 plus cisplatin during induction chemotherapy for small-cell lung cancer.  Academic Article
• The use of chemotherapy in patients with advanced malignant pleural mesothelioma: a systematic review and practice guideline.  Academic Article
• Thromboembolism in children with acute lymphoblastic leukaemia treated on Dana-Farber Cancer Institute protocols: effect of age and risk stratification of disease  Academic Article
• Thrombosis in Children with Acute Lymphoblastic Leukemia Treated at a Tertiary Care Center in Lebanon: Revisiting the Role of Predictive Models  Academic Article
• Timing of CMF chemotherapy in combination with tamoxifen in postmenopausal women with breast cancer: role of endocrine responsiveness of the tumor  Academic Article
• Tirapazamine with cisplatin in patients with advanced non-small-cell lung cancer: a phase II study.  Academic Article
• Tolerance of Radiotherapy and Chemotherapy in Elderly Patients With Bladder Cancer  Academic Article
• Topoisomerase II Alpha and Responsiveness of Breast Cancer to Adjuvant Chemotherapy  Academic Article
• Topoisomerase II alpha protein and responsiveness of breast cancer to adjuvant chemotherapy with CEF compared to CMF in the NCIC CTG randomized MA.5 adjuvant trial  Academic Article
• Toxic megacolon associated with anticancer chemotherapy.  Academic Article
• Translating clinical trials to clinical practice: outcomes of men with metastatic castration resistant prostate cancer treated with docetaxel and prednisone in and out of clinical trials  Academic Article
• Trastuzumab emtansine (T-DM1) in patients with HER2-positive metastatic breast cancer and brain metastases: exploratory final analysis of cohort 1 from KAMILLA, a single-arm phase IIIb clinical trial☆  Academic Article
• Treatment of Hodgkin lymphoma with adriamycin, bleomycin, vinblastine and dacarbazine without routine granulocyte-colony stimulating factor support does not increase the risk of febrile neutropenia: a prospective cohort study  Academic Article
• Treatment of advanced Hodgkin's disease with chemotherapy--comparison of MOPP/ABV hybrid regimen with alternating courses of MOPP and ABVD: a report from the National Cancer Institute of Canada clinical trials group.  Academic Article
• Treatment of early epithelial ovarian cancer with chemotherapy and abdominopelvic radiotherapy: results of a prospective treatment protocol  Conference Paper
• Treatment of patients with acute nonlymphocytic leukemia in relapse: A leukemia intergroup study  Academic Article
• Treatment strategies in elderly patients with aggressive histology lymphoma.  Academic Article
• Treatment with topotecan plus cyclophosphamide in children with first relapse of neuroblastoma  Academic Article
• Treatment-emergent hypertension and outcomes in patients with advanced non-small-cell lung cancer receiving chemotherapy with or without the vascular endothelial growth factor receptor inhibitor cediranib: NCIC Clinical Trials Group Study BR24  Academic Article
• Two Phase I Studies of Carboplatin Dose Escalation in Chemotherapy-Naive Ovarian Cancer Patients Supported With Patients Supported With Granulocyte-Macrophage Colony-Stimulating Factor  Academic Article
• UCN-01 in combination with topotecan in patients with advanced recurrent ovarian cancer: A study of the Princess Margaret Hospital Phase II consortium  Academic Article
• Unresected stage III non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group.  Academic Article
• Updated results from the phase 3 HELIOS study of ibrutinib, bendamustine, and rituximab in relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma  Academic Article
• Use of granulocyte colony-stimulating factor (G-CSF) in patients receiving myelosuppressive chemotherapy for the treatment of cancer. Provincial Systemic Treatment Disease Site Group.  Academic Article
• Use of human dura in pediatric chest wall reconstruction after tumor resection  Conference Paper
• VIncristine, irinotecan, and temozolomide in children and adolescents with relapsed rhabdomyosarcoma  Academic Article
• Vaginal Yolk Sac Tumor in an Infant  Academic Article
• Validated or Not Validated? That Is the Question  Academic Article
• Validation of an algorithmic nutritional approach in children undergoing chemotherapy for cancer  Academic Article
• Validation of the Association of RECIST Changes With Survival in Men With Metastatic Castration-Resistant Prostate Cancer Treated on SWOG Study S0421  Academic Article
• Weekly Intravenous Methotrexate with Folinic Acid for Nonmetastatic Gestational Trophoblastic Neoplasia  Academic Article
• Weekly cyclophosphamide and alternate-day prednisone: an effective secondary therapy in multiple myeloma.  Academic Article
• Weight gain in breast cancer survivors: prevalence, pattern and health consequences  Academic Article
• Women's perceptions of home-based exercise performed during adjuvant chemotherapy for breast cancer  Academic Article
• [The significance of hormone receptor content in primary tumors for cytostatic therapy of advanced breast carcinoma].  Academic Article